EGM
TAK icon

Engineers Gate Manager’s Takeda Pharmaceutical TAK Stock Holding History

Engineers Gate Manager’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$712K Buy
+44,396
New +$735K 0.01% 1279
2026
Q1 		– Sell
-41,134
Closed -$641K – 2555
2025
Q4 		$641K Buy
41,134
+8,480
+26% +$121K 0.01% 1244
2025
Q3 		$478K Buy
32,654
+19,092
+141% +$284K 0.01% 1539
2025
Q2 		$210K Sell
13,562
-1,228
-8% -$18.1K ﹤0.01% 1878
2025
Q1 		$220K Buy
+14,790
New +$207K ﹤0.01% 1851
2024
Q2 		– Sell
-26,184
Closed -$364K – 2234
2024
Q1 		$364K Buy
26,184
+10,803
+70% +$157K 0.01% 1367
2023
Q4 		$219K Buy
+15,381
New +$218K 0.01% 1597
2023
Q2 		– Sell
-10,703
Closed -$176K – 2031
2023
Q1 		$176K Sell
10,703
-4,543
-30% -$72.4K 0.01% 1449
2022
Q4 		$238K Buy
15,246
+1,621
+12% +$22.6K 0.01% 1298
2022
Q3 		$177K Sell
13,625
-15,954
-54% -$222K 0.01% 1352
2022
Q2 		$415K Buy
29,579
+14,117
+91% +$202K 0.02% 1215
2022
Q1 		$221K Sell
15,462
-9,423
-38% -$138K 0.01% 1577
2021
Q4 		$339K Buy
+24,885
New +$349K 0.02% 1316
2021
Q2 		– Sell
-13,600
Closed -$248K – 2006
2021
Q1 		$248K Buy
+13,600
New +$245K 0.01% 1452
2020
Q3 		– Sell
-12,899
Closed -$231K – 1976
2020
Q2 		$231K Buy
+12,899
New +$232K 0.01% 1370

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Engineers Gate Manager's TAK Position: Q2 2026 in Review

Engineers Gate Manager opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 44,396 shares worth $712K. The stake represents 0.01% of the portfolio and ranks #1279 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in TAK as recently as Q4 2025.

Engineers Gate Manager first reported a position in TAK in Q2 2020 and has held it in 15 quarters since. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Engineers Gate Manager held 44,396 shares of Takeda Pharmaceutical worth $712K as of Q2 2026.
  • Takeda Pharmaceutical was a new Engineers Gate Manager position in Q2 2026.
  • Takeda Pharmaceutical made up 0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1279 holding.
  • Engineers Gate Manager first reported a position in Takeda Pharmaceutical in Q2 2020 and has held it in 15 quarters since.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.